The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Herpesvirus 3, Human

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Herpesvirus 3, Human


High impact information on Herpesvirus 3, Human


Chemical compound and disease context of Herpesvirus 3, Human


Biological context of Herpesvirus 3, Human


Anatomical context of Herpesvirus 3, Human


Gene context of Herpesvirus 3, Human


Analytical, diagnostic and therapeutic context of Herpesvirus 3, Human


  1. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. Greenspan, J.S., Greenspan, D., Lennette, E.T., Abrams, D.I., Conant, M.A., Petersen, V., Freese, U.K. N. Engl. J. Med. (1985) [Pubmed]
  2. Recent advances in varicella-zoster virus infection. Cohen, J.I., Brunell, P.A., Straus, S.E., Krause, P.R. Ann. Intern. Med. (1999) [Pubmed]
  3. Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus. Tappero, J.W., Perkins, B.A., Wenger, J.D., Berger, T.G. Clin. Microbiol. Rev. (1995) [Pubmed]
  4. The DNA binding domains of the varicella-zoster virus gene 62 and herpes simplex virus type 1 ICP4 transactivator proteins heterodimerize and bind to DNA. Tyler, J.K., Everett, R.D. Nucleic Acids Res. (1994) [Pubmed]
  5. Helicase-primase complex of herpes simplex virus type 1: a mutation in the UL52 subunit abolishes primase activity. Klinedinst, D.K., Challberg, M.D. J. Virol. (1994) [Pubmed]
  6. A controlled trial of acyclovir for chickenpox in normal children. Dunkle, L.M., Arvin, A.M., Whitley, R.J., Rotbart, H.A., Feder, H.M., Feldman, S., Gershon, A.A., Levy, M.L., Hayden, G.F., McGuirt, P.V. N. Engl. J. Med. (1991) [Pubmed]
  7. Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine. Shepp, D.H., Dandliker, P.S., Meyers, J.D. N. Engl. J. Med. (1986) [Pubmed]
  8. Reliability of a history of previous varicella infection in adults. Wallace, M.R., Chamberlin, C.J., Zerboni, L., Sawyer, M.H., Oldfield, E.C., Olson, P.E., Arvin, A.M. JAMA (1997) [Pubmed]
  9. Antibodies to varicella-zoster virus in blood donors with genetic variance in CC chemokine receptor 5. Zhang, M., Schmid, S., Carrington, M., O'Brien, T.R. Lancet (2002) [Pubmed]
  10. A tyrosine-based motif and a casein kinase II phosphorylation site regulate the intracellular trafficking of the varicella-zoster virus glycoprotein I, a protein localized in the trans-Golgi network. Alconada, A., Bauer, U., Hoflack, B. EMBO J. (1996) [Pubmed]
  11. Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection. Safrin, S., Berger, T.G., Gilson, I., Wolfe, P.R., Wofsy, C.B., Mills, J., Biron, K.K. Ann. Intern. Med. (1991) [Pubmed]
  12. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Moffat, J.F., Zerboni, L., Sommer, M.H., Heineman, T.C., Cohen, J.I., Kaneshima, H., Arvin, A.M. Proc. Natl. Acad. Sci. U.S.A. (1998) [Pubmed]
  13. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir. Spector, T., Harrington, J.A., Morrison, R.W., Lambe, C.U., Nelson, D.J., Averett, D.R., Biron, K., Furman, P.A. Proc. Natl. Acad. Sci. U.S.A. (1989) [Pubmed]
  14. Gene activation by Varicella-zoster virus IE4 protein requires its dimerization and involves both the arginine-rich sequence, the central part, and the carboxyl-terminal cysteine-rich region. Baudoux, L., Defechereux, P., Rentier, B., Piette, J. J. Biol. Chem. (2000) [Pubmed]
  15. Disseminated varicella-zoster virus infection with the syndrome of inappropriate antidiuretic hormone. Ingraham, I.E., Estes, N.A., Bern, M.M., DeGirolami, P.C. Arch. Intern. Med. (1983) [Pubmed]
  16. Characterization of Varicella-Zoster virus glycoprotein K (open reading frame 5) and its role in virus growth. Mo, C., Suen, J., Sommer, M., Arvin, A. J. Virol. (1999) [Pubmed]
  17. Identification of the phosphorylation sequence in the cytoplasmic tail of the varicella-zoster virus Fc receptor glycoprotein gpI. Yao, Z., Jackson, W., Grose, C. J. Virol. (1993) [Pubmed]
  18. New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. Davison, A.J., Edson, C.M., Ellis, R.W., Forghani, B., Gilden, D., Grose, C., Keller, P.M., Vafai, A., Wroblewska, Z., Yamanishi, K. J. Virol. (1986) [Pubmed]
  19. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. LaRussa, P., Lungu, O., Hardy, I., Gershon, A., Steinberg, S.P., Silverstein, S. J. Virol. (1992) [Pubmed]
  20. Endocytosis and recycling of varicella-zoster virus Fc receptor glycoprotein gE: internalization mediated by a YXXL motif in the cytoplasmic tail. Olson, J.K., Grose, C. J. Virol. (1997) [Pubmed]
  21. Deoxypyrimidine nucleoside metabolism in varicella-zoster virus-infected cells. Hackstadt, T., Mallavia, L.P. J. Virol. (1978) [Pubmed]
  22. Varicella-zoster virus ORF47 protein kinase, which is required for replication in human T cells, and ORF66 protein kinase, which is expressed during latency, are dispensable for establishment of latency. Sato, H., Pesnicak, L., Cohen, J.I. J. Virol. (2003) [Pubmed]
  23. Quantitation of latent varicella-zoster virus DNA in human trigeminal ganglia by polymerase chain reaction. Mahalingam, R., Wellish, M., Lederer, D., Forghani, B., Cohrs, R., Gilden, D. J. Virol. (1993) [Pubmed]
  24. Role of cytoplasmic vacuoles in varicella-zoster virus glycoprotein trafficking and virion envelopment. Jones, F., Grose, C. J. Virol. (1988) [Pubmed]
  25. Polymerase chain reaction detection and clinical significance of varicella-zoster virus in cerebrospinal fluid from human immunodeficiency virus-infected patients. Burke, D.G., Kalayjian, R.C., Vann, V.R., Madreperla, S.A., Shick, H.E., Leonard, D.G. J. Infect. Dis. (1997) [Pubmed]
  26. Immediate-early transcription over covalently joined genome ends of bovine herpesvirus 1: the circ gene. Fraefel, C., Wirth, U.V., Vogt, B., Schwyzer, M. J. Virol. (1993) [Pubmed]
  27. Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus. Taylor, S.L., Kinchington, P.R., Brooks, A., Moffat, J.F. J. Virol. (2004) [Pubmed]
  28. Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. Wang, J.P., Kurt-Jones, E.A., Shin, O.S., Manchak, M.D., Levin, M.J., Finberg, R.W. J. Virol. (2005) [Pubmed]
  29. Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase. Ye, M., Duus, K.M., Peng, J., Price, D.H., Grose, C. J. Virol. (1999) [Pubmed]
  30. The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter. Meier, J.L., Luo, X., Sawadogo, M., Straus, S.E. Mol. Cell. Biol. (1994) [Pubmed]
  31. Glycoprotein gp118 of varicella-zoster virus: purification by serial affinity chromatography. Friedrichs, W.E., Grose, C. J. Virol. (1984) [Pubmed]
  32. 2'-Fluoro-5-iodoarabinosylcytosine, a new potent antiviral agent: efficacy in immunosuppressed individuals with herpes zoster. Leyland-Jones, B., Donnelly, H., Groshen, S., Myskowski, P., Donner, A.L., Fanucchi, M., Fox, J. J. Infect. Dis. (1986) [Pubmed]
  33. Antigen detection: the method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patients. Dahl, H., Marcoccia, J., Linde, A. J. Clin. Microbiol. (1997) [Pubmed]
  34. Sensitivity of different assay systems for immunoglobulin M responses to varicella-zoster virus in reactivated infections (zoster). Schmidt, N.J., Arvin, A.M. J. Clin. Microbiol. (1986) [Pubmed]
  35. Postexposure prophylaxis of varicella in family contact by oral acyclovir. Asano, Y., Yoshikawa, T., Suga, S., Kobayashi, I., Nakashima, T., Yazaki, T., Ozaki, T., Yamada, A., Imanishi, J. Pediatrics (1993) [Pubmed]
WikiGenes - Universities